These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8353318)

  • 61. GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine model.
    Dufu K; Alt C; Strutt S; Partridge J; Tang T; Siu V; Liao-Zou H; Rademacher P; Williams AT; Muller CR; Geng X; Pochron MP; Dang AN; Cabrales P; Li Z; Oksenberg D; Cathers BE
    Br J Haematol; 2023 Jul; 202(1):173-183. PubMed ID: 36960712
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vanillin, a potential agent for the treatment of sickle cell anemia.
    Abraham DJ; Mehanna AS; Wireko FC; Whitney J; Thomas RP; Orringer EP
    Blood; 1991 Mar; 77(6):1334-41. PubMed ID: 2001455
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis.
    Du E; Diez-Silva M; Kato GJ; Dao M; Suresh S
    Proc Natl Acad Sci U S A; 2015 Feb; 112(5):1422-7. PubMed ID: 25605910
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Unraveling DEHP influence on hemoglobin S polymerization in sickle cell disease: Ex vivo, in vitro and in silico analysis.
    Camacho RA; Machado AV; de Oliveira Mendonça F; Teixeira-Alves LR; Guimarães-Nobre CC; Mendonça-Reis E; da Silva PF; Cardim-Pires TR; Miranda-Alves L; Berto-Junior C
    Toxicol In Vitro; 2024 Jun; 98():105832. PubMed ID: 38653437
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Molecular and cellular pathophysiology of sickle cell anemia].
    Labie D; Elion J
    Pathol Biol (Paris); 1999 Jan; 47(1):7-12. PubMed ID: 10081773
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The paradox of hemoglobin SC disease.
    Nagel RL; Fabry ME; Steinberg MH
    Blood Rev; 2003 Sep; 17(3):167-78. PubMed ID: 12818227
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interspecies hybrid HbS: complete neutralization of Val6(beta)-dependent polymerization of human beta-chain by pig alpha-chains.
    Rao MJ; Malavalli A; Manjula BN; Kumar R; Prabhakaran M; Sun DP; Ho NT; Ho C; Nagel RL; Acharya AS
    J Mol Biol; 2000 Jul; 300(5):1389-406. PubMed ID: 10903876
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Non-uniformity of intracellular polymer formation in sickle erythrocytes: possible correlation with severity of hemolytic anemia.
    Noguchi CT; Schechter AN
    Am J Pediatr Hematol Oncol; 1984; 6(1):46-50. PubMed ID: 6711762
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.
    Ueda Y; Bookchin RM
    J Lab Clin Med; 1984 Aug; 104(2):146-59. PubMed ID: 6431043
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Viscoelastic properties of sickle cells and hemoglobin.
    Chien S; King RG; Kaperonis AA; Usami S
    Blood Cells; 1982; 8(1):53-64. PubMed ID: 7115978
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hydration of sickle cells using the sodium ionophore Monensin. A model for therapy.
    Clark MR; Mohandas N; Shohet SB
    J Clin Invest; 1982 Nov; 70(5):1074-80. PubMed ID: 7130394
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Two-step mechanism of homogeneous nucleation of sickle cell hemoglobin polymers.
    Galkin O; Pan W; Filobelo L; Hirsch RE; Nagel RL; Vekilov PG
    Biophys J; 2007 Aug; 93(3):902-13. PubMed ID: 17449671
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell disease.
    Marcus SJ; Kinney TR; Schultz WH; O'Branski EE; Ware RE
    Am J Hematol; 1997 Jan; 54(1):40-6. PubMed ID: 8980259
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sickle hemoglobin polymerization in solution and in cells.
    Noguchi CT; Schechter AN
    Annu Rev Biophys Biophys Chem; 1985; 14():239-63. PubMed ID: 3890882
    [No Abstract]   [Full Text] [Related]  

  • 75. Pathogenesis of sickle cell disease.
    Eaton JW; Hebbel RP
    Pathobiol Annu; 1981; 11():31-52. PubMed ID: 7036055
    [No Abstract]   [Full Text] [Related]  

  • 76. Therapeutic strategies in Sickle Cell Anemia: The past present and future.
    Fernandes Q
    Life Sci; 2017 Jun; 178():100-108. PubMed ID: 28435037
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (second of three parts).
    Dean J; Schechter AN
    N Engl J Med; 1978 Oct; 299(15):804-11. PubMed ID: 692564
    [No Abstract]   [Full Text] [Related]  

  • 78. Determination of deoxyhemoglobin S polymer in sickle erythrocytes upon deoxygenation.
    Noguchi CT; Torchia DA; Schechter AN
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5487-91. PubMed ID: 6933568
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The intracellular polymerization of sickle hemoglobin and its relevance to sickle cell disease.
    Noguchi CT; Schechter AN
    Blood; 1981 Dec; 58(6):1057-68. PubMed ID: 7030432
    [No Abstract]   [Full Text] [Related]  

  • 80. Genome-wide association study of erythrocyte density in sickle cell disease patients.
    Ilboudo Y; Bartolucci P; Rivera A; Sedzro JC; Beaudoin M; Trudel M; Alper SL; Brugnara C; Galactéros F; Lettre G
    Blood Cells Mol Dis; 2017 Jun; 65():60-65. PubMed ID: 28552477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.